ask="2.58"
ask_size="700"
average_daily_volume="238560"
bid="2.00"
bid_size="100"
book_value="3.15"
change="-0.10"
change_from_200_day_moving_average="-0.11"
change_from_50_day_moving_average="0.33"
change_from_52_week_high="-5.71"
change_From_52_week_low="0.89"
change_in_percent="-3.73%"
close="2.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.70"
ebitda="-56.49M"
eps_estimate_current_year="-5.24"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="14677000"
high="2.69"
high_52_weeks="8.29"
last_trade_date="1/19/2017"
last_trade_price="2.58"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.55"
low_52_weeks="1.69"
market_capitalization="52.24M"
moving_average_200_day="2.69"
moving_average_50_day="2.25"
name="Aptevo Therapeutics Inc."
notes="N/A"
one_year_target_price="5.00"
open="2.69"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.99%"
percent_change_from_50_day_moving_average="+14.91%"
percent_change_from_52_week_high="-68.88%"
percent_change_from_52_week_low="+52.66%"
previous_close="2.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.85"
price_per_sales="1.51"
revenue="35.95M"
shares_outstanding="20248000"
short_ratio="2.06"
stock_exchange="NMS"
symbol="APVO"
volume="45086"
weeks_range_52="1.69 - 8.29"
